Agenda (minutes) - CSRPG 2018-02-20
Date
20-February, 2018
GoToMeeting Details
Attendees
Former user (Deleted)
Deborah Drake (Unlicensed)
Jim Campbell
Former user (Deleted)
Laszlo Igali (Unlicensed)
Former user (Deleted)
Former user (Deleted)
r.dash (Unlicensed)
Former user (Deleted)
Apologies
Ian Green
Objectives
Revisit last month's discussion on synoptic report use
Review melanoma work at UNMC
Discuss CDA for pathology
Discussion items
Item | Description | Owner | Notes | Action |
|---|---|---|---|---|
1 | Conflict of Interest | Scott Campbell |
| |
2 | Synoptic Report scope/use | Scott Campbell | CAP use of synoptic report is for primary neoplasm and when a pTNM stage (primary neoplasm resection vs. diagnostic biopsy) can be determined/assigned. This addresses the concern of defining histology types for worksheet. |
|
3 | Review current UNMC melanoma check sheet | Scott Campbell | Output file looks fine. Add to confluence and include version/HL7 message sample and human readable version |
|
4 | CDA for pathology reports | Jim Campbell | All agree that this is a good approach. Ask to rename molecular pathology to broader term ~ genomics or genetics |
|
5 | Other business (IHE,PaLM prep meeting)
| Scott Campbell |
|
|
Meeting Files
Previous Meetings